BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3118447)

  • 1. Fibrinolytic activity in medium from tissue culture of paranasal mucous membrane.
    Kosugi T; Nakamura M; Koja S; Haraguchi S; Noda Y
    Rhinology; 1987 Sep; 25(3):195-8. PubMed ID: 3118447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some chemical properties of tissue plasminogen activator purified from paranasal mucous membrane.
    Kosugi T; Nakamura M; Tsukayama T; Haraguchi S; Noda Y
    Rhinology; 1987 Jun; 25(2):129-32. PubMed ID: 3112919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on proactivator from the paranasal mucous membrane in chronic sinusitis.
    Kosugi T; Takagi I; Kinjo K; Ura M; Okamoto K; Sueno K; Mihara H
    Rhinology; 1983 Dec; 21(4):309-13. PubMed ID: 6686718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of fibrinolytic enzymes in inflammation and paranasal mucous membrane.
    Kosugi T; Kinjo K; Takagi I; Sueno K; Noda Y; Mihara M
    Rhinology; 1984 Jun; 22(2):119-23. PubMed ID: 6540472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of proactivator from tissue plasminogen activator with low molecular weight in the paranasal mucous membrane.
    Kosugi T; Takagi I; Ariga Y; Kinjo K; Matayoshi S; Noda Y
    Auris Nasus Larynx; 1982; 9(2):99-104. PubMed ID: 6891585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin binding, fibrinolytic and fibrinogenolytic activity of plasminogen activator derived from the paranasal mucous membrane of humans.
    Yamashiro Y; Nakamura M; Huang GW; Kosugi T
    Laryngoscope; 1993 Feb; 103(2):197-202. PubMed ID: 8426513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of tissue plasminogen activator from paranasal mucous membrane in chronic sinusitis.
    Kosugi T; Matsuo O; Mihara H; Hirano K; Hamaya M
    Ann Otol Rhinol Laryngol; 1982; 91(1 Pt 1):101-5. PubMed ID: 7041770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
    Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
    Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hepatoma cell line plasminogen activator.
    Levin EG; Fair DS; Loskutoff DJ
    J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator in human megakaryocytes and platelets: immunocytochemical localization, immunoblotting and zymographic analysis.
    Jeanneau C; Sultan Y
    Thromb Haemost; 1988 Jun; 59(3):529-34. PubMed ID: 3142087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
    Diamond MP; Kruger M; Saed GM
    Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oxidized regenerated cellulose (Interceed) on the expression of tissue plasminogen activator and plasminogen activator inhibitor-1 in human peritoneal fibroblasts and mesothelial cells.
    Gago LA; Saed G; Elhammady E; Diamond MP
    Fertil Steril; 2006 Oct; 86(4 Suppl):1223-7. PubMed ID: 17008148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
    Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration.
    Morimoto K; Mishima H; Nishida T; Otori T
    Thromb Haemost; 1993 Apr; 69(4):387-91. PubMed ID: 8497852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
    Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N
    Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultrastructural study of the mucosa of the human paranasal sinuses in normal and pathological states].
    Kumami T
    Nihon Jibiinkoka Gakkai Kaiho; 1969 Jul; 72(7):1221-31. PubMed ID: 5388909
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
    Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.